MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, EDIT made $40,520K in revenue. -$160,060K in net income. Net profit margin of -395.01%.

Income Overview

Revenue
$40,520K
Net Income
-$160,060K
Net Profit Margin
-395.01%
EPS
-$1.8
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Collaboration and other research and development revenues
40,520
Research and development
89,953
General and administrative
49,903
Restructuring and impairment charges
60,674
Total operating expenses
200,530
Operating loss
-160,010
Interest expense related to sale of future revenues
6,171
Interest income, net
8,310
Other expense, net
-2,189
Total other income (expense), net
-50
Net loss
-160,060
Basic EPS
-1.8
Diluted EPS
-1.8
Basic Average Shares
88,745,908
Diluted Average Shares
88,745,908
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$160,060K Operating loss-$160,010K Total other income(expense), net-$50K Collaboration and otherresearch and development...$40,520K Interest income, net$8,310K Total operatingexpenses$200,530K Interest expense relatedto sale of future...$6,171K Other expense, net-$2,189K Research and development$89,953K Restructuring and impairmentcharges$60,674K General andadministrative$49,903K

Editas Medicine, Inc. (EDIT)

Editas Medicine, Inc. (EDIT)